Preclinical Pharmacology Characterization of Sovleplenib (HMPL-523), an Orally Available Syk Inhibitor

作者：Yu Cai, Jianlin He, Zhipeng Wu, Weigang He, Xiaoming Dai, Yan Xu, Min Cheng, Na Yang, Yongxin Ren, Guanglin Wang, Jian Wang, Yang Sai, Hong Jia, Guangxiu Dai, Xiong Li, Weiguo Su · 发表于：Journal of Pharmacology and Experimental Therapeutics · 年份：2023 · DOI：10.1124/jpet.123.001752 · 被引用次数：10 · 研究领域：Mast cells and histamine、Monoclonal and Polyclonal Antibodies Research、Platelet Disorders and Treatments